BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Severson TJ, Besur S, Bonkovsky HL. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World J Gastroenterol 2016; 22(29): 6742-6756 [PMID: 27547017 DOI: 10.3748/wjg.v22.i29.6742]
URL: https://www.wjgnet.com/1007-9327/full/v22/i29/6742.htm
Number Citing Articles
1
Umar Hayat, Ali A. Siddiqui, Muhammad L. Farhan, Ahmed Haris, Nasir Hameed. Genome Editing in Cardiovascular and Metabolic DiseasesAdvances in Experimental Medicine and Biology 2023; 1396: 191 doi: 10.1007/978-981-19-5642-3_13
2
Ming Qiao, Jian-hua Yang, Yi Zhu, Jun-ping Hu. Association of sorting and assembly machinery component 50 homolog gene polymorphisms with nonalcoholic fatty liver disease susceptibilityMedicine 2022; 101(29): e29958 doi: 10.1097/MD.0000000000029958
3
Zheng-Jie Xu, Jun-Ping Shi, De-Rong Yu, Li-Juan Zhu, Ji-Dong Jia, Jian-Gao Fan. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study DesignAdvances in Therapy 2016; 33(11): 2069 doi: 10.1007/s12325-016-0416-4
4
Szkup Małgorzata, Brodowski Jacek, Owczarek Aleksander Jerzy, Choręza Piotr, Jurczak Anna, Grochans Elżbieta. Searching for Factors Raising the Incidence of Metabolic Syndrome Among 45-60-Year-Old WomenAging and disease 2018; 9(5): 831 doi: 10.14336/AD.2017.1027
5
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål, Hannes Hagström. Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐upLiver International 2022; 42(12): 2769 doi: 10.1111/liv.15438
6
Teruki Miyake, Yoichi Hiasa. The Evolving Landscape of Liver Cirrhosis Management2019; : 1 doi: 10.1007/978-981-13-7979-6_1
7
Ann P. Walker. Ischaemic stroke and liver fibrosisAtherosclerosis 2017; 260: 153 doi: 10.1016/j.atherosclerosis.2017.03.028
8
Ali Saeed, Robin Dullaart, Tim Schreuder, Hans Blokzijl, Klaas Faber. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)Nutrients 2017; 10(1): 29 doi: 10.3390/nu10010029
9
Daniel F. Mazo, Fernanda M. Malta, Jose Tadeu Stefano, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Jazon R. Almeida, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed populationAnnals of Hepatology 2019; 18(3): 466 doi: 10.1016/j.aohep.2018.10.004
10
T. Herta, J. Fischer, T. Berg. Genetik metabolischer und viraler LebererkrankungenDer Gastroenterologe 2017; 12(1): 16 doi: 10.1007/s11377-016-0128-y
11
Fita Nur Jannah, Putri Diyah Anggraini, Abdul Gofur, Sri Rahayu Lestari. The prevention of single bulb garlic extract on non-alcoholic fatty liver disease (NAFLD) in high fat mice (Mus musculus) modelINTERNATIONAL CONFERENCE ON LIFE SCIENCES AND TECHNOLOGY (ICoLiST 2020) 2021; 2353: 030095 doi: 10.1063/5.0052672
12
Manu V. Chakravarthy, Brent A. Neuschwander‐Tetri. The metabolic basis of nonalcoholic steatohepatitisEndocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.112
13
Kareem M Abdelraheem, Nahla N Younis, Mohamed A Shaheen, Sahar E Elswefy, Sousou I Ali. Raspberry ketone improves non-alcoholic fatty liver disease induced in rats by modulating sphingosine kinase/sphingosine-1-phosphate and toll-like receptor 4 pathwaysJournal of Pharmacy and Pharmacology 2023; 75(7): 985 doi: 10.1093/jpp/rgad044
14
V. Nathan Subramaniam. Ironing out SteatohepatitisAnnals of Hepatology 2017; 16(1): 8 doi: 10.5604/16652681.1226809
15
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical TreatmentsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.603926
16
Ashraf K. Awaad, Maher A. Kamel, Magdy M. Mohamed, Madiha H. Helmy, Magda I. Youssef, Eiman I. Zaki, Marwa M. Essawy, Marwa G. A. Hegazy. The role of hepatic transcription factor cAMP response element-binding protein (CREB) during the development of experimental nonalcoholic fatty liver: a biochemical and histomorphometric studyEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00046-8
17
Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisInternal Medicine 2022; 19(1): 61 doi: 10.2478/inmed-2022-0198
18
Chaonan Xu, Zhimin Ma, Yunfeng Wang, Xiangtong Liu, Lixin Tao, Deqiang Zheng, Xiuhua Guo, Xinghua Yang. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4‐year follow‐upLiver International 2018; 38(12): 2294 doi: 10.1111/liv.13941
19
Maddi Oses, Cristina Cadenas‐Sanchez, María Medrano, Arkaitz Galbete, Emiliano Miranda‐Ferrua, Jonatan R. Ruiz, Felix Sánchez‐Valverde, Francisco B. Ortega, Rafael Cabeza, Arantxa Villanueva, Fernando Idoate, Idoia Labayen. Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesityPediatric Obesity 2022; 17(9) doi: 10.1111/ijpo.12917
20
Anna L. Lang, Juliane I. Beier. Interaction of volatile organic compounds and underlying liver disease: a new paradigm for riskBiological Chemistry 2018; 399(11): 1237 doi: 10.1515/hsz-2017-0324
21
Quelson Coelho Lisboa, Mateus Jorge Nardelli, Patrícia de Araújo Pereira, Débora Marques Miranda, Stephanie Nunes Ribeiro, Raissa Soares Neves Costa, Camila Azevedo Versiani, Paula Vieira Teixeira Vidigal, Teresa Cristina de Abreu Ferrari, Claudia Alves Couto. <i>PNPLA3</i> and <i>TM6SF2 </i>polymorphisms in Brazilian patients with nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2020; 12(10): 792-806 doi: 10.4254/wjh.v12.i10.792
22
Darina Falbová, Lenka Vorobeľová, Daniela Siváková, Radoslav Beňuš. Association betweenFTO(rs17817449) genetic variant, gamma‐glutamyl transferase, and hypertension in Slovak midlife womenAmerican Journal of Human Biology 2022; 34(4) doi: 10.1002/ajhb.23672
23
Efstathia Thymiakou, Alaa Othman, Thorsten Hornemann, Dimitris Kardassis. Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4AMetabolism 2020; 110: 154307 doi: 10.1016/j.metabol.2020.154307
24
Sarah E. Kleinstein, Matthew Rein, Manal F. Abdelmalek, Cynthia D. Guy, David B. Goldstein, Anna Mae Diehl, Cynthia A. Moylan. Whole‐Exome Sequencing Study of Extreme Phenotypes of NAFLDHepatology Communications 2018; 2(9): 1021 doi: 10.1002/hep4.1227
25
Leanne Hodson, Pippa J. Gunn. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional stateNature Reviews Endocrinology 2019; 15(12): 689 doi: 10.1038/s41574-019-0256-9
26
Muhammad Imran, Frédéric Chalmel, Odile Sergent, Bertrand Evrard, Hélène Le Mentec, Antoine Legrand, Aurélien Dupont, Maëlle Bescher, Simon Bucher, Bernard Fromenty, Laurence Huc, Lydie Sparfel, Dominique Lagadic-Gossmann, Normand Podechard. Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposureCell Biology and Toxicology 2023; 39(2): 371 doi: 10.1007/s10565-022-09706-4
27
Wenpei Liu, Lihuan Lu, Hongqiu Pan, Xiaomin He, Meiling Zhang, Nannan Wang, Jia Zhu, Honggang Yi, Shaowen Tang. Heme Oxygenase-1 and Hemopexin Gene Polymorphisms and the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity in ChinaPharmacogenomics 2022; 23(7): 431 doi: 10.2217/pgs-2022-0015
28
Xiaoyi Xu, Hangfei Xu, Xiaohui Liu, Shuang Zhang, Zhenhuan Cao, Lixia Qiu, Xiaofei Du, Yali Liu, Gang Wang, Li Zhang, Yang Zhang, Jing Zhang. MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese populationFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1199429
29
Jose D. Torres-Peña, Laura Martín-Piedra, Francisco Fuentes-Jiménez. Statins in Non-alcoholic SteatohepatitisFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.777131
30
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative ReviewIranian Biomedical Journal 2022; 26(4): 252 doi: 10.52547/ibj.3647
31
Ruth Schübel, Tobias Nonnenmacher, Disorn Sookthai, Sandra Gonzalez Maldonado, Solomon A. Sowah, Oyunbileg von Stackelberg, Christopher L. Schlett, Mirja Grafetstätter, Diana Nabers, Theron Johnson, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Tilman Kühn, Johanna Nattenmüller. Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLDNutrients 2019; 11(3): 544 doi: 10.3390/nu11030544
32
Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis CBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01654-3
33
Fernando Bessone, María Valeria Razori, Marcelo G. Roma. Molecular pathways of nonalcoholic fatty liver disease development and progressionCellular and Molecular Life Sciences 2019; 76(1): 99 doi: 10.1007/s00018-018-2947-0
34
Yen‐Po Lin, Yu‐Chieh Tsai, Mu Jung Tsai, Pao‐Yuan Huang, Chien‐Hung Chen, Chih‐Chien Yao, Seng‐Kee Chuah, Yuan‐Hung Kuo, Wei‐Chen Tai, Wei‐Shiung Lian, Hsin‐Wei Fang, Tsung‐Hui Hu, Ming‐Chao Tsai. Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individualsAdvances in Digestive Medicine 2024; 11(3): 129 doi: 10.1002/aid2.13367
35
Renata Risi, Dario Tuccinardi, Stefania Mariani, Carla Lubrano, Silvia Manfrini, Lorenzo Maria Donini, Mikiko Watanabe. Liver disease in obesity and underweight: the two sides of the coin. A narrative reviewEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2021; 26(7): 2097 doi: 10.1007/s40519-020-01060-w
36
Ludovico Abenavoli, Natasa Milic, Francesco Luzza, Luigi Boccuto, Antonino De Lorenzo. Polyphenols treatment in patients with nonalcoholic fatty liver diseaseJournal of Translational Internal Medicine 2017; 5(3): 144 doi: 10.1515/jtim-2017-0027
37
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese PatientsCurrent Hepatology Reports 2017; 16(4): 382 doi: 10.1007/s11901-017-0377-3
38
Miaomiao Yang, Haiping Zhang, Bilin Tao, Hongqiu Pan, Lihuan Lu, Honggang Yi, Shaowen Tang. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control studyJournal of Clinical Pharmacy and Therapeutics 2019; 44(4): 534 doi: 10.1111/jcpt.12818
39
Rohini Mehta, Kianoush Jeiran, Aaron B. Koenig, Munkzhul Otgonsuren, Zachary Goodman, Ancha Baranova, Zobair Younossi. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)BMC Medical Genetics 2016; 17(1) doi: 10.1186/s12881-016-0324-0
40
Dan L. Longo, Anna M. Diehl, Christopher Day. Cause, Pathogenesis, and Treatment of Nonalcoholic SteatohepatitisNew England Journal of Medicine 2017; 377(21): 2063 doi: 10.1056/NEJMra1503519
41
Claudia Phen, Charina M. Ramirez. Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic WorkupClinical Liver Disease 2021; 17(3): 191 doi: 10.1002/cld.1008
42
Alberto Lopez, Jose Aguilar. A Data Analysis Smart System for the Optimal Deployment of Nanosensors in the Context of an eHealth ApplicationAlgorithms 2023; 16(2): 81 doi: 10.3390/a16020081
43
Giuseppina R Umano, Sonia Caprio, Anna Di Sessa, Naga Chalasani, Daniel J Dykas, Bridget Pierpont, Allen E Bale, Nicola Santoro. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese YouthAmerican Journal of Gastroenterology 2018; 113(3): 376 doi: 10.1038/ajg.2018.1
44
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran. Non-alcoholic Fatty Liver Disease: A Clinical UpdateJournal of Clinical and Translational Hepatology 2017; (XX): XX doi: 10.14218/JCTH.2017.00013
45
Aaron B. Koenig, Albert Tan, Hala Abdelaal, Fanny Monge, Zobair M. Younossi, Zachary D. Goodman. Review article: Hepatic steatosis and its associations with acute and chronic liver diseasesAlimentary Pharmacology & Therapeutics 2024; 60(2): 167 doi: 10.1111/apt.18059
46
Uijin Kim, Nahyun Kim, Ha Youn Shin. Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using “Good-Fit” Genome-Editing ToolsCells 2020; 9(12): 2572 doi: 10.3390/cells9122572
47
Ligiane Marques Loureiro, Suzane Lessa, Rodrigo Mendes, Sílvia Pereira, Carlos José Saboya, Andrea Ramalho. Does the Metabolically Healthy Obese Phenotype Protect Adults with Class III Obesity from Biochemical Alterations Related to Bone Metabolism?Nutrients 2019; 11(9): 2125 doi: 10.3390/nu11092125
48
Charlotte J. Green, Siôn A. Parry, Pippa J. Gunn, Carlo D.L. Ceresa, Fredrik Rosqvist, Marie-Eve Piché, Leanne Hodson. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human modelsHormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2018-0038
49
Donglei Sun, Tianhe Zhao, Qian Zhang, Mei Wu, Zunzhen Zhang. Fat mass and obesity‐associated protein regulates lipogenesis via m6A modification in fatty acid synthase mRNACell Biology International 2021; 45(2): 334 doi: 10.1002/cbin.11490
50
Elena Corradini, Elena Buzzetti, Paola Dongiovanni, Stefania Scarlini, Angela Caleffi, Serena Pelusi, Isabella Bernardis, Paolo Ventura, Raffaela Rametta, Elena Tenedini, Enrico Tagliafico, Anna Ludovica Fracanzani, Silvia Fargion, Antonello Pietrangelo, Luca Vittorio Valenti. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLDJournal of Hepatology 2021; 75(3): 506 doi: 10.1016/j.jhep.2021.03.014
51
Zhan Gu, Yan Bi, Fan Yuan, Ruirui Wang, Dong Li, Jianying Wang, Xiaojuan Hu, Guang He, Lei Zhang, Bao-cheng Liu. <p><em>FTO</em> Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population</p>Clinical Interventions in Aging 2020; : 1333 doi: 10.2147/CIA.S254740
52
Sixing Shen, Lingyan Pan. Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta‑analysisExperimental and Therapeutic Medicine 2024; 27(3) doi: 10.3892/etm.2024.12387
53
Chiara Compagnoni, Roberta Capelli, Veronica Zelli, Alessandra Corrente, Davide Vecchiotti, Irene Flati, Mauro Di Vito Nolfi, Adriano Angelucci, Edoardo Alesse, Francesca Zazzeroni, Alessandra Tessitore. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 ExpressionInternational Journal of Molecular Sciences 2023; 24(11): 9239 doi: 10.3390/ijms24119239
54
Oluwafolajimi Adesanya, Diptatanu Das, Auinash Kalsotra. Emerging roles of RNA‐binding proteins in fatty liver diseaseWIREs RNA 2024; 15(2) doi: 10.1002/wrna.1840
55
Yue Feng, Yanlin Li, Wenduo Jiang, Yun Hu, Yimin Jia, Ruqian Zhao. GR-mediated transcriptional regulation of m6A metabolic genes contributes to diet-induced fatty liver in hensJournal of Animal Science and Biotechnology 2021; 12(1) doi: 10.1186/s40104-021-00642-7
56
Giulia Bellini, Emanuele Miraglia del Giudice, Valerio Nobili, Francesca Rossi. The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese childrenJournal of Hepatology 2017; 67(3): 653 doi: 10.1016/j.jhep.2017.02.037
57
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeuticsProstaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
58
Pablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodriguez-Frias, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, Juan M. Pericàs, David Martinez Selva. Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver FibrosisBiomedicines 2022; 10(5): 1015 doi: 10.3390/biomedicines10051015
59
Omar E. Hegazi, Samer O. Alalalmeh, Ghala Rashid Humaid Alnuaimi, Moyad Shahwan, Ammar Abdulrahman Jairoun, Nasser M. Alorfi, Shaker A. Majrashi, Mustfa Faisal Alkhanani, Abdullah Alkhattabi, Mansour M. Alourfi, Faris A. Alsolami, Saeed Alsharif, Hatim Alshahrani. NAFLD and nutraceuticals: a review of completed phase III and IV clinical trialsFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1227046
60
Jose D. Torres-Peña, Antonio P. Arenas-de Larriva, Juan F. Alcala-Diaz, Jose Lopez-Miranda, Javier Delgado-Lista. Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature ReviewNutrients 2023; 15(6): 1483 doi: 10.3390/nu15061483
61
Herbert L. Bonkovsky, Tyler Severson, Paola Nicoletti, Huiman Barnhart, Jose Serrano, Naga Chalasani, Robert J. Fontana, Paul B. Watkins, Victor Navarro, Andrew Stolz, Ann K. Daly, Guruparasad P. Aithal, Joseph Odin. Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver InjuryHepatology Communications 2019; 3(8): 1032 doi: 10.1002/hep4.1382
62
Somaya Albhaisi, Arun J. Sanyal. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic SteatohepatitisFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.665987
63
Kuniko Yamamoto, Tomomi Kogiso, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige. Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver diseaseJGH Open 2019; 3(1): 17 doi: 10.1002/jgh3.12097
64
Casimiro Castillejo-López, José Ramón Bárcenas-Walls, Marco Cavalli, Anders Larsson, Claes Wadelius. A regulatory element associated to NAFLD in the promoter of DIO1 controls LDL-C, HDL-C and triglycerides in hepatic cellsLipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02029-9
65
Joseph Boachie, Antonysunil Adaikalakoteswari, Jinous Samavat, Ponnusamy Saravanan. Low Vitamin B12 and Lipid Metabolism: Evidence from Pre-Clinical and Clinical StudiesNutrients 2020; 12(7): 1925 doi: 10.3390/nu12071925
66
O.E. Abaturov, A.O. Nikulina. Genetic predisposition to metabolic dysfunction-associated fatty liver diseaseCHILD`S HEALTH 2024; 19(3): 162 doi: 10.22141/2224-0551.19.3.2024.1696
67
Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese. The burden of liver disease in Latin AmericaAnnals of Hepatology 2024; 29(3): 101175 doi: 10.1016/j.aohep.2023.101175
68
Haleh Chehrehgosha, Masoud Reza Sohrabi, Faramarz Ismail-Beigi, Mojtaba Malek, Mohammad Reza Babaei, Farhad Zamani, Hossein Ajdarkosh, Mahmood Khoonsari, Afshin Eshghi Fallah, Mohammad E. Khamseh. Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialDiabetes Therapy 2021; 12(3): 843 doi: 10.1007/s13300-021-01011-3
69
Sana Raza, Archana Tewari, Sangam Rajak, Rohit A. Sinha. Vitamins and non-alcoholic fatty liver disease: A molecular insightLiver Research 2021; 5(2): 62 doi: 10.1016/j.livres.2021.03.004
70
Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi, Isabella Franco, Tamara Lippolis, Rosalba D’Alessandro, Maria Grazia Refolo, Caterina Messa. Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle InterventionsInternational Journal of Molecular Sciences 2021; 22(8): 3899 doi: 10.3390/ijms22083899
71
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigmsWorld Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
72
Antonina Kedyk, Oleksandr Kutsyn. Metabolic effects of empagliflozineDiabetes Obesity Metabolic Syndrome 2022; (5): 38 doi: 10.57105/2415-7252-2022-5-04
73
Luma Melo, Merve Bilici, Amit Hagar, James E. Klaunig. The effect of endurance training on non‐alcoholic fatty liver disease in micePhysiological Reports 2021; 9(15) doi: 10.14814/phy2.14926
74
Qun Liu, Shou-Sheng Liu, Zhen-Zhen Zhao, Ben-Tian Zhao, Shui-Xian Du, Wen-Wen Jin, Yong-Ning Xin. TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han populationLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1108-2